Exodus Point Capital Management, LP Infinity Pharmaceuticals, Inc. Transaction History

Exodus Point Capital Management, LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$1.52 - $3.82 $69,198 - $173,905	-45,525 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$2.66 - $3.47 $374,956 - $489,134	-140,961 Reduced 75.59%	45,525 $136,000
Q1 2021 May 17, 2021	BUY	$1.98 - $5.36 $369,242 - $999,564	186,486 New	186,486 $602,000

1.27M

Ticker INFI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 89,277,904
Description
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.